AIDS News and Research RSS Feed - AIDS News and Research

Clinic-based audio project gives HIV patients a chance to share experiences with diagnosis

Clinic-based audio project gives HIV patients a chance to share experiences with diagnosis

The voice on the recording was low and calm as the speaker recounted the telephone call that brought the news he was infected with the human immunodeficiency virus (HIV) that causes AIDS: "My heart just stopped for a little bit and next thing you know I was on the floor flat on my face boohooing, crying like a baby." [More]
Researchers find that considerable proportion of infections discovered outside hospital setting

Researchers find that considerable proportion of infections discovered outside hospital setting

More than 80 percent of hospitalized patients who tested positive for Clostridium difficile were tested outside the hospital or within the first 72 hours of hospitalization, suggesting that settings outside of the hospital may play key roles in the identification, onset and possible transmission of the disease, according to a new Kaiser Permanente study published today in the journal Mayo Clinic Proceedings. [More]
New momentum: WHO welcomes progress in tackling viral hepatitis

New momentum: WHO welcomes progress in tackling viral hepatitis

On World Hepatitis Day, 28 July, WHO welcomes new progress in tackling one of the world's most serious diseases. Viral hepatitis - a group of infectious diseases known as hepatitis A, B, C, D, and E - affects millions of people worldwide, causing acute and chronic liver disease and killing close to 1.4 million people every year. [More]
Pilot study shows that anti-cancer drug can activate hidden HIV

Pilot study shows that anti-cancer drug can activate hidden HIV

A pilot study by HIV researchers from Aarhus University and Aarhus University Hospital in Denmark has shown that an anti-cancer drug can activate hidden HIV. [More]
Chemclin's HIV kits for in-vitro qualitative determination of Anti-HIV 1+2

Chemclin's HIV kits for in-vitro qualitative determination of Anti-HIV 1+2

Chemclin's HIV kits are available for in-vitro qualitative determination of Antibody to Human Immunodeficiency Virus Type 1 and Type 2 (Anti-HIV 1+2) and P24 antigen of HIV in human serum or plasma by a sandwich chemiluminescent assay method. [More]
State highlights: Iowa invests in autism program; rural docs feel the pinch of Wisconsin's low Medicaid payments

State highlights: Iowa invests in autism program; rural docs feel the pinch of Wisconsin's low Medicaid payments

A selection of health policy stories from New York, Missouri, Texas, Massachusetts, Maine, Georgia and Pennsylvania. [More]
Black women who strongly identified with race more likely to feel anxious in healthcare setting

Black women who strongly identified with race more likely to feel anxious in healthcare setting

A first-of-its-kind study by researchers at USC and Loyola Marymount University (LMU) has found evidence that the persistent health disparities across race may, in part, be related to anxiety about being confronted by negative racial stereotypes while receiving healthcare. [More]
Study shows correlation between education and nearsightedness

Study shows correlation between education and nearsightedness

Education and behavior have a greater impact on the development of nearsightedness than do genetic factors: With each school year completed, a person becomes more nearsighted. [More]

Deaths still rippling through AIDS research community

As the airport lounge filled with passengers waiting to board Malaysia Airlines Flight 17, a renowned professor rushed to the gate while texting a colleague, saying that he was "superbusy." Veering into the business-class line, Joep Lange, an AIDS researcher, passed a former election observer who had just returned from Ukraine. [More]
First Edition: July, 21, 2014

First Edition: July, 21, 2014

Today's headlines include a story about an effort by regulators to widen insurer networks, as well as a range of other health policy developments. [More]
EGPAF experts to deliver presentations at AIDS 2014

EGPAF experts to deliver presentations at AIDS 2014

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations, moderate conference events, and exhibit a variety of educational posters and abstracts related to ending AIDS in children. [More]
Drug for reduction of abdominal fat in HIV patients may also reduce fatty liver disease

Drug for reduction of abdominal fat in HIV patients may also reduce fatty liver disease

The only drug to receive FDA approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients. [More]
Psychology residency training program receives federal funding for 5th consecutive grant cycle

Psychology residency training program receives federal funding for 5th consecutive grant cycle

A psychology residency training program that's a joint effort of the Medical College of Georgia at Georgia Regents University and the Charlie Norwood Veterans Affairs Medical Center has received federal funding for the fifth consecutive grant cycle. [More]
Growth hormone reduces liver fat in HIV-infected patients with excess abdominal fat

Growth hormone reduces liver fat in HIV-infected patients with excess abdominal fat

In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. [More]

Men do not engage in riskier behaviors after circumcision

Men do not engage in riskier behaviors after they are circumcised, according to a study in Kenya by University of Illinois at Chicago researchers. [More]
HIV self-testing increases proportion of adults initiating antiretroviral therapy

HIV self-testing increases proportion of adults initiating antiretroviral therapy

Among adults in the African country of Malawi offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating antiretroviral therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. [More]
New guidelines integrate biomedical advances and behavioral interventions for HIV people

New guidelines integrate biomedical advances and behavioral interventions for HIV people

In an innovative approach to HIV prevention, an interdisciplinary group of experts has come together for the first time to lay out a framework of best practices to optimize the role of the clinician in achieving an AIDS-free generation. [More]

Annual HIV diagnosis rate in the U.S. decreases more than 30%: Study

The annual HIV diagnosis rate in the U.S. decreased more than 30 percent from 2002-2011, with declines observed in several key populations, although increases were found among certain age groups of men who have sex with men, especially young men, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. [More]
Learning role of immune-system cells in digestive tracts may lead to new treatments for IBS

Learning role of immune-system cells in digestive tracts may lead to new treatments for IBS

Learning the role of immune-system cells in healthy digestive tracts and how they interact with neighboring nerve cells may lead to new treatments for irritable bowel syndrome (IBS). [More]
Researchers find viable immunotherapy option for HIV-1 using fossil virus

Researchers find viable immunotherapy option for HIV-1 using fossil virus

The road to finding a cure for HIV-1 is not without obstacles. However, thanks to cutting-edge research by Douglas Nixon, M.D., Ph.D., and colleagues, performed at the George Washington University (GW), Oregon Health & Science University, the University of Rochester, and UC San Francisco, the scientific community is one step closer to finding a viable immunotherapy option for HIV-1, using an immune attack against a fossil virus buried in the genome. [More]